Financial terms of the deal were not disclosed.
Medline’s Erase BSI is meant to standardize best practices around central lines post-insertion, reducing cases of bloodstream infections.
On top of its minor procedure trays, Centurion makes vascular insertion trays and securement dressings that complement Erase BSI.
“The addition of Centurion to the Medline family gives us a complete product offering in the vascular access market and brings more depth to our Infection Prevention solutions for customers,” Jim Pigott, group division president at Medline (Northfield, Ill.), said in a news release.
“As healthcare’s focus increasingly moves towards prevention, we are ensuring we can meet and anticipate the needs of providers in this area,” Pigott said.
Centurion will continue to operate as a subsidiary of Medline.